Advertise on podcast: Springer Health+ IME: Podcast to Practice

Rating

★★★★★

from

1 reviews

Description

Podcast to Practice is the expert-led independent medical educational series aimed at healthcare professionals, brought to you by Springer Health+ IME. Each episode features leading clinical experts in their respective fields, covering a broad range of disease states from the well studied oncology, to lesser known rare diseases. Podcast to Practice discusses latest evidence-based research, clinical guidelines and expert discussions around diagnosis, therapies, and patient management, inspiring healthcare professionals to maximise their learning and make measurable change in their own clinical practice. Podcast to Practice is a production of Springer Health+ IME, the global independent medical educational provider. More info is available at https://ime.springerhealthplus.com

Unlock Springer Health+ IME: Podcast to Practice podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Springer Health+ IME: Podcast to Practice podcast

It’s a team effort: Collaborative care in bladder cancer | S15E3

2026/10/16

Join Enrique Grande and Maria Lapuente as they explore patient-centered and multidisciplinary approaches to treatment decision-making, patient education, and adverse event management for newer bladder cancer therapies.

Rethinking perioperative approaches in MIBC | S15E2

2026/10/16

Join Enrique Grande and Michiel van der Heijden as they review the latest evidence supporting perioperative treatment strategies in MIBC, before exploring how evolving biomarkers such as ctDNA and utDNA may help guide risk assessment, treatment selection, and future bladder-preservation strategies.

What comes next? Sequencing therapies in advanced UC | S15E1

2026/10/16

Join Enrique Grande and María T Bourlon as they discuss guideline-recommended treatment selection and sequencing in advanced urothelial carcinoma, before exploring the evolving role of biomarkers and how newer therapies are redefining treatment success.

Future directions in HER2-positive NSCLC | S14E3

2026/10/09

This expert-to-expert 3 part podcast series looks at the advances in the management of HER2-positive NSCLC, designed for time-pressured clinicians.

Practical considerations for implementation of HER2-targeted therapies | S14E2

2026/10/09

This expert-to-expert 3 part podcast series looks at the advances in the management of HER2-positive NSCLC, designed for time-pressured clinicians.

HER2 biomarker testing in practice | S14E1

2026/10/09

This expert-to-expert 3 part podcast series looks at the advances in the management of HER2-positive NSCLC, designed for time-pressured clinicians.

Addressing Barriers to CGM Adoption in T2 Diabetes | S13E1

2026/10/02

Dr. Kristen Flint and patient Michelle discuss the day-to-day realities of living with type 2 diabetes, real-world perspectives on continuous glucose monitoring, and shared decision-making.

Setting expectations for PC-IOLs | S12E4

2026/07/31

Dr. Jennifer Loh and Dr. Caroline Watson discuss the importance of patient communication, including managing outcome and financial expectations, in PC-IOL surgery.

Mapping the surgical journey | S12E3

2026/07/31

Dr. Jennifer Loh and Dr. Caroline Watson explore a stepwise workflow of PC-IOL surgery and formula optimization including individualized calculations and mathematical approaches.

Diagnostics that drive decisions | S12E2

2026/07/31

Dr. Jennifer Loh and Dr. Rahul Tonk walk through presbyopia-correcting intraocular lens (PC-IOL) preoperative diagnostics and discuss the landscape of PC-IOL technologies.

Presbyopia: Where are we now? | S12E1

2026/07/31

Dr. Jennifer Loh and Dr. Rahul Tonk provide an overview of presbyopia including the impact on quality of life, economic considerations and current trends in PC-IOLs.

Ensuring equitable access to targeted therapies: the regulatory perspective | S11E2

2026/07/27

In this video podcast, Dr. Justin Gainor and Dr. Sanjay Popat examine the evolving regulatory and clinical landscape of TRK inhibitors for NTRK fusion–positive NSCLC. They discuss the biology of oncogenic fusions, the evidence supporting current targeted therapies, and the challenges of developing and approving treatments for ultra‑rare molecular subsets. Their conversation highlights global differences in regulatory pathways, barriers to molecular testing, and the need for innovative trial designs and real‑world evidence to advance precision oncology.

Navigating NTRK: the patient perspective | S11E1

2026/07/27

In this video podcast, Dr. Justin Gainor and patient advocate Stevan Bradford discuss the lived experience of NTRK fusion–positive NSCLC, covering the path to diagnosis, the importance of biomarker testing, and the challenges of starting treatment. They share practical insights on targeted therapy, side effect management, and improving communication and personalized care, highlighting the vital role of the patient voice in precision oncology.

Understanding the Full Burden of LGS | S10E2

2026/02/18

International experts Andreea Nissenkorn, Antonio Gil-Nagel Rein and Takamichi Yamamoto examine the burden of disease, offering a holistic view of the real-world burden of Lennox-Gastaut syndrome on patients and caregivers.

Recognizing Lennox-Gastaut Syndrome | S10E1

2026/02/18

International experts Andreea Nissenkorn, Antonio Gil-Nagel Rein and Takamichi Yamamoto elucidate the neurophysiological and genetic factors underpinning Lennox-Gastaut syndrome, highlighting key pathophysiological processes.